NEW YORK (TheStreet) -- CHANGE IN RATINGS
L Brands (LB) was downgraded to hold at TheStreet Ratings.
Myriad Genetics (MYGN) was downgraded from market perform to underperform at JMP Securities. Twelve-month price target is $15. BRCA pricing is lower than expected, JMP Securities said.
SP Plus (SP) was upgraded to buy at TheStreet Ratings.
[Read: 4 Stocks Ready for Breakouts]
Stock Comments / EPS Changes
Expedia's (EXPE) 12-month price target was raised at Cantor Fitzgerald. Shares are now seen reaching $75. Checks point to higher site visitation in recent months, Cantor Fitzgerald said. Buy rating.